Table 1 HIV Genotypic Resistance Mutations for Patients Engaging in Sexual Risk
Antiretroviral Class Resistance and Number of Patients With Resistance | Mutation* and % of Patients With a Mutation |
|---|---|
Nucleoside reverse transcriptase inhibitor (N = 29) | 215Y/F/C/S/D (79%) 184V (52%) 41L (34%) 219Q/E (34%) 70R (28%) 67N (10%) 74V (3%) 151M (3%) 69SSS (3%) |
Nonnucleoside reverse transcriptase inhibitor (N = 15) | 103N (53%) 181C (40%) 190A/S (38%) |
Protease inhibitor (N = 16) | 90M (50%) 82A/F/D (31%) 30N (20%) 84V (6%) 48V (6%) |